{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Pseudoisocytidine",
  "nciThesaurus": {
    "casRegistry": "57100-18-2",
    "chebiId": "",
    "chemicalFormula": "C9H13N3O5",
    "definition": "A synthetic, pyrimidine C-5 nucleoside with antineoplastic activity. Pseudoisocytidine, after conversion into pseudoisocytidine triphosphate, is incorporated into DNA and RNA eventually halting tumor cell proliferation. Compared to 5-azacytidine and cytarabine, this agent shows enhanced stability and resistance to enzymatic deamination.",
    "fdaUniiCode": "TDH73L8XQD",
    "identifier": "C87389",
    "preferredName": "Pseudoisocytidine",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1557"
    ],
    "synonyms": [
      "4(1H)-Pyrimidinone, 2-Amino-5-Beta-D-Ribofuranosyl-",
      "5-(Beta-D-Ribofuranosyl)Isocytosine",
      "PSEUDOISOCYTIDINE",
      "Pseudoisocytidine",
      "psi Icyd"
    ]
  }
}